Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study.
Shiratori S, Fukushima K, Onishi Y, Doki N, Goto T, Okada M, Nakamae H, Maeda Y, Kato K, Ishikawa T, Kondo T, Toyosaki M, Ikeda T, Uchida N, Maki A, Shimada F, Tajima T, Stefanelli T, Teshima T. Shiratori S, et al. Among authors: toyosaki m. Int J Hematol. 2024 Oct 3. doi: 10.1007/s12185-024-03850-9. Online ahead of print. Int J Hematol. 2024. PMID: 39361234
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S. Ohwada C, et al. Among authors: toyosaki m. Biol Blood Marrow Transplant. 2020 Jan;26(1):162-170. doi: 10.1016/j.bbmt.2019.09.016. Epub 2019 Sep 16. Biol Blood Marrow Transplant. 2020. PMID: 31536824 Free article. Clinical Trial.
An Open-Label, Single-Arm, Multicenter Study of Ibrutinib in Japanese Patients With Steroid-dependent/Refractory Chronic Graft-Versus-Host Disease.
Doki N, Toyosaki M, Shiratori S, Osumi T, Okada M, Kawakita T, Sawa M, Ishikawa T, Ueda Y, Yoshinari N, Nakahara S. Doki N, et al. Among authors: toyosaki m. Transplant Cell Ther. 2021 Oct;27(10):867.e1-867.e9. doi: 10.1016/j.jtct.2021.05.019. Epub 2021 Jun 6. Transplant Cell Ther. 2021. PMID: 34102349 Free article. Clinical Trial.
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Harada K, Morita-Fujita M, Fukuda T, Ozawa Y, Doki N, Toyosaki M, Maruyama Y, Kanda Y, Ashida T, Eto T, Takada S, Uchida N, Ichinohe T, Kanda J, Onizuka M, Atsuta Y, Kako S, Arai Y. Harada K, et al. Among authors: toyosaki m. Cytotherapy. 2022 Sep;24(9):954-961. doi: 10.1016/j.jcyt.2022.03.004. Epub 2022 May 7. Cytotherapy. 2022. PMID: 35534419 Free article.
Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation.
Harada K, Najima Y, Kato M, Fuji S, Shinohara A, Nakamae H, Toyosaki M, Ashiarai M, Onizuka M, Hashii Y, Ichinohe T, Atsuta Y, Nakasone H. Harada K, et al. Among authors: toyosaki m. Int J Hematol. 2022 Nov;116(5):744-753. doi: 10.1007/s12185-022-03405-w. Epub 2022 Jun 29. Int J Hematol. 2022. PMID: 35767142
Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome.
Hara R, Kitahara T, Numata H, Toyosaki M, Watanabe S, Kikkawa E, Ogawa Y, Kawada H, Ando K. Hara R, et al. Among authors: toyosaki m. Int J Hematol. 2023 May;117(5):684-693. doi: 10.1007/s12185-022-03523-5. Epub 2022 Dec 27. Int J Hematol. 2023. PMID: 36574168
37 results